Skip to main content
    B

    Briacell Therapeutics Corp (BCTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.30
    -0.09 (-2.65%)

    Market Cap: $29.60M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Briacell Therapeutics Corp (BCTX) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Briacell Therapeutics are Barinthus Biotherapeutics (BRNS), Grace Therapeutics (GRCE) and Oncolytics Biotech (ONCY). By market cap, Briacell Therapeutics ranks 9th of the 13 companies on this page; iBio, Inc. Common Stock (IBIO) is the largest at $51.55M.

    Peer Comparison

    BCTX's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Briacell Therapeutics (BCTX)$29.60MN/AN/A0.0%N/A0.0%0.00%
    Barinthus Biotherapeutics plc (BRNS)$30.23MN/AN/A0.0%N/A-100.0%0.00%
    Grace Therapeutics, Inc. (GRCE)$38.08MN/AN/A0.0%N/A0.0%0.00%
    Oncolytics Biotech Inc (ONCY)$48.51MN/AN/A0.0%N/A0.0%0.00%
    Connect Biopharma Holdings Ltd (CNTB)$42.65MN/A13.6x0.0%N/A5667.0%0.00%
    Celularity Inc (CELU)$20.45MN/A1.0x-245.7%N/A-5.3%0.00%
    Telomir Pharmaceuticals, Inc. Common Stock (TELO)$36.15MN/AN/A0.0%N/A0.0%0.00%
    Plus Therapeutics Inc (PSTV)$26.64MN/A2.0x-230.2%-827.8%-2.9%0.00%
    Biomea Fusion Inc (BMEA)$42.31MN/AN/A0.0%N/A0.0%0.00%
    Edesa Biotech Inc (EDSA)$26.21MN/AN/A0.0%N/A-99.9%0.00%
    iBio, Inc. Common Stock (IBIO)$51.55MN/A735.4x0.0%N/A975.0%0.00%
    Biovie Inc (BIVI)$12.12MN/AN/A0.0%N/A0.0%0.00%
    Instil Bio Inc. (TIL)$41.23MN/AN/A0.0%-11.9%0.0%0.00%
    Peer median$37.11MN/A7.8x0.0%-419.9%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Briacell Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Barinthus Biotherapeutics plc (BRNS)
    Barinthus Biotherapeutics plc, a clinical-stage biopharmaceutical company, engages in developing novel T cell immunotherapeutics to guide the immune system...
    BRNS competitors
    Grace Therapeutics, Inc. (GRCE)
    Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.
    GRCE competitors
    Oncolytics Biotech Inc (ONCY)
    Oncolytics Biotech Inc., a developing-stage biopharmaceutical company, focuses on the discovery and development of pharmaceuticals for the treatment of cancer.
    ONCY competitors
    Connect Biopharma Holdings Ltd (CNTB)
    Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, is focused on the discovery and development of immune modulators...
    CNTB competitors
    Celularity Inc (CELU)
    Celularity Inc. is a pioneering biotechnology company focused on regenerative medicine through its innovative cellular products derived from the placenta.
    CELU competitors
    Telomir Pharmaceuticals, Inc. Common Stock (TELO)
    Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human...
    TELO competitors
    Plus Therapeutics Inc (PSTV)
    Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing...
    PSTV competitors
    Biomea Fusion Inc (BMEA)
    Biomea Fusion, Inc., a biopharmaceutical company, is focused on the discovery, development and commercialization of irreversible small molecules to treat...
    BMEA competitors
    Edesa Biotech Inc (EDSA)
    Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, is engaged in the research and development...
    EDSA competitors
    iBio, Inc. Common Stock (IBIO)
    iBio, Inc., a biotech company, provides contract development and manufacturing services to outside partners and customers in the United States.
    IBIO competitors
    Biovie Inc (BIVI)
    BioVie Inc., a clinical-stage biotechnology company, is dedicated to the discovery, development, and commercialization of drug therapies in the United States.
    BIVI competitors
    Instil Bio Inc. (TIL)
    Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer patients.
    TIL competitors

    Frequently Asked Questions About BCTX

    Who are Briacell Therapeutics' main competitors?

    The companies most similar to Briacell Therapeutics include Barinthus Biotherapeutics (BRNS), Grace Therapeutics (GRCE), Oncolytics Biotech (ONCY), Connect Biopharma Holdings (CNTB) and Celularity (CELU), listed from the closest match.

    Who is Briacell Therapeutics' biggest competitor?

    iBio, Inc. Common Stock (IBIO) is the largest of the similar companies at $51.55M; Barinthus Biotherapeutics (BRNS) is the closest match by business profile, size, sector and industry.

    How does BCTX stock compare with its competitors?

    BCTX's net margin is 0.0% against a peer median of 0.0%.

    Which of Briacell Therapeutics' competitors pays a higher dividend?

    Briacell Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Briacell Therapeutics bigger than its competitors?

    No. Briacell Therapeutics is 9th by market cap among the 13 companies on this page; the largest is iBio, Inc. Common Stock (IBIO) at $51.55M.